[1] HARTMAN-KSYCIŃSKA A, KLUZ-ZAWADZKA J, LEWANDOWSKI B. High Altitude Illness[J]. Przegl Epidemiol, 2016, 70(3): 490-499. [2] MALLET RT, BURTSCHER J, PIALOUX V, et al.Molecular Mechanisms of High-Altitude Acclimatization[J]. International Journal of Molecular Sciences, 2023, 24(2): 1698. [3] LIU R, XU C, ZHANG W, et al.FUNDC1-Mediated Mitophagy and HIF1α Activation Drives Pulmonary Hypertension during Hypoxia[J]. Cell Death and Disease, 2022, 13(7): 634. [4] SURESH MV, BALIJEPALLI S, SOLANKI S, et al.Hypoxia-Inducible Factor 1α and Its Role in Lung Injury: Adaptive or Maladaptive[J]. Inflammation, 2023, 46(2): 491-508. [5] CAO J, LUO JY, WU D, et al.Effect of Vascular Endothelial Growth Factor A on Pulmonary Vascular Remodeling in Neonatal Rats with Hypoxic Pulmonary Hypertension and Its Mechanism[J]. Chinese Journal of Pediatrics(中国当代儿科杂志), 2021, 23(1): 103-110. [6 ] LI CY, CAO WJ, HUANG Y, et al. Study on the Intervention Effect of Dabufei Decoction on Acute Lung Injury in Rats with High Altitude Hypoxia Based on HIF-1α/NLRP3 Signaling Pathway[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2024, 41(6): 736-742. [7] PENG Y.A Critical Review on Phytochemical Profile and Biological Effects of Turnip (Brassica rapa L.)[J]. Frontiers in Nutrition, 2021, 29(8): 721-733. [8] WANG S, ZHANG L, ZHOU Y, et al.A Review on Pharmacokinetics of Sinomenine and Its Anti-Inflammatory and Immunomodulatory Effects[J]. International Immunopharmacology, 2023, 119: 110-227. [9] GUAN JJ.Protective Effect and Mechanism of Sinomenine on Acute Lung Injury in Mice[J]. Zhejiang Journal of Integrated Chinese and Western Medicine(浙江中西医结合杂志), 2020, 30(9): 709-712. [10] ZENG Q, XIAO W, JIANG Y.Effect of Sinomenine Hydrochloride on Lung Injury in Sepsis Mice[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2021, 37(18): 2468-2471. [11] WILKINS MR, GHOFRANI HA, WEISSMANN N, et al.Pathop-hysiology and Treatment of High-Altitude Pulmonary Vascular Disease[J]. Circulation, 2015, 131(6): 582-590. [12] DUNHAM-SNARY KJ, WU D, SYKES EA, et al.Hypoxic Pulmonary Vasoconstriction[J]. Chest, 2017, 151(1): 181-192. [13] CHEN B, YUAN DZ, FU Y.Effect of Stage Intervention of Yunyao Tianlong exhaustion on Lung Tissue Remodeling and Lung Function in Rats with Pulmonary Fibrosis[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2024, 21(5): 540-546. [14] SU Y, LUCAS R, FULTON DJR, et al.Mechanisms of Pulmonary Endothelial Barrier Dysfunction in Acute Lung Injury and Acute Respiratory Distress Syndrome[J]. Chinese Medical Journal: Pulmonary and Critical Care Medicine, 2024, 2(2): 80-87. [15] YE Y, XU Q, WUREN T.Inflammation and Immunity in the Pathogenesis of Hypoxic Pulmonary Hypertension[J]. Frontiers in Immunology, 2023, 5(14): 1162556. [16] POSEY JN, JORDAN M, LEWIS CV, et al.Nbeal2 Knockout Mice Are not Protected Against Hypoxia-Induced Pulmonary Vascular Remodeling and Pulmonary Hypertension[J]. Blood Advances, 2025, 9(7): 1571-1584. [17] NA L, XIONG Z, QING H.Vascular Endothelial Growth Factor and High-Altitude Pulmonary Edema[J]. Advances in Cardiovascular Diseases(心血管病学进展), 2019, 40(2): 188-191. [18] LIU J, WANG W, WANG L, et al.IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells[J]. EBioMedicine, 2018, 33: 196-210. [19] SONG ZF, LI ZP.Research Progress of Traditional Chinese Medicine in Inhibiting Angiogenesis of Liver Cancer Based on the HIF-1α/VEGF Pathway[J]. Traditional Medicine of Asia and the Pacific(亚太传统医药), 2022, 18(9): 201-206. |